Juliana Mota Siqueira

The University of Texas MD Anderson Cancer Center

Also affiliated with Universidade de São Paulo, Hospital Israelita Albert Einstein

MedicineDentistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report”.

First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report

JCO Precision Oncology(2024)10.1200/po.23.00633

N/A

0.254DataRank · unranked

3 citations

Eduardo Andreazza Dal Lago, Juliana Mota Siqueira, Luana Guimarães de Sousa, Adel K. El‐Naggar, Jordi Rodón +2 more

Axitinib plus avelumab for recurrent/metastatic adenoid cystic carcinoma (R/M ACC): Biomarker analysis of the phase II trial.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.6104

N/A

0DataRank · unranked

0 citations

Daniel J. McGrail, Yoshitsugu Mitani, Simon Heeke, Luana Guimarães de Sousa, Erison Santos +8 more